| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,250 | $30 | $212.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 12,150 | $10 | $133.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,850 | $30 | $126.1K |
| J3262 | Injection, tocilizumab, 1 mg | 15,960 | $10 | $79.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 360 | $90 | $32.6K |
| J0897 | Injection, denosumab, 1 mg | 1,800 | $20 | $32.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $110 | $29.8K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 270 | $20 | $4.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 30 | $130 | $4.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 70 | $60 | $3.8K |